The Skin Cancer Channel

Explore the latest updates, including expert interviews and features
Latest Videos Conferences Subtypes Topics Podcasts

Welcome to the Skin Cancer Channel!

VJOncology brings you the latest developments in the field of skin cancer, keeping you up-to-date with the most exciting developments with video interviews, podcasts, and roundtable discussions, and more.

Reporting from key international congresses, catch up on the key advances in skin cancer, including the use of novel treatment approaches, key trial updates as well as expert opinions in clinical approaches.

Conferences

ASCO 2023
AACR 2023
ESMO 2022
ASCO 2022
EADO 2022
AACR 2022
1:40
MATISSE: nivolumab in cutaneous squamous cell carcinoma
Charlotte Zuur • 4 Jun 2023
1:27
Validating MIA & MSKCC predictive tool for melanoma sentinel node status
Roger Olofsson Bagge • 4 Jun 2023
1:22
The personalization of neoadjuvant immunotherapy in stage III melanoma
Minke Lucas • 4 Jun 2023
0:40
Gamma signature guidance in optimizing neoadjuvant immunotherapy for resectable melanoma
Minke Lucas • 4 Jun 2023
View All Videos
1:26
The future of personalized, neoantigen cancer vaccines
Jeffrey Weber • 20 Apr 2023
4:10
A personalized mRNA vaccine with pembrolizumab in melanoma
Jeffrey Weber • 20 Apr 2023
2:20
The potential impact of lifileucel on the treatment landscape of melanoma
Omid Hamid • 17 Apr 2023
1:17
Intratumoral MEDI1191 encoding IL-12 in solid tumors
Omid Hamid • 18 Apr 2023
View All Videos
0:35
Potential advantages of neoadjuvant immunotherapy for melanoma
Sapna Patel • 12 Sep 2022
0:27
SWOG S1801: Escalation vs. deescalation of immunotherapy for melanoma
Sapna Patel • 12 Sep 2022
1:40
SWOG S1801: Benefits of neoadjuvant immunotherapy for patients with resectable melanoma
Sapna Patel • 12 Sep 2022
1:28
Highlights from ESMO 2022 in melanoma
Omid Hamid • 12 Sep 2022
View All Videos
2:26
Overcoming barriers in treating melanoma brain metastases
Bently Doonan • 7 Jun 2022
3:51
Evaluating the mechanism of action of emavusertib
Bently Doonan • 7 Jun 2022
0:39
Pembrolizumab, emavusterib + radiosurgery: a novel trimodal therapy for metastatic melanoma
Bently Doonan • 14 Jun 2022
1:20
Resistance to immune checkpoint blockade in patients with cSCC
Paolo Bossi • 5 Jun 2022
View All Videos
1:48
The management of squamous cell carcinoma
Antonio Tejera-Vaquerizo • 20 Apr 2022
1:24
Is there a role for sentinel lymph node biopsy in squamous cell carcinoma?
Antonio Tejera-Vaquerizo • 20 Apr 2022
1:14
Adjuvant and neoadjuvant clinical trials for melanoma
Eva Muñoz Couselo • 26 Apr 2022
1:03
Treating metastatic melanoma
Eva Muñoz Couselo • 26 Apr 2022
View All Videos
2:28
Future directions for research in non-melanoma skin cancer
Omid Hamid • 11 Apr 2022
1:03
Mechanism of action of the novel SEMA4D inhibitor, pepinemab
Terrence L. Fisher • 12 Apr 2022
1:13
KEYNOTE-B84: pepinemab + pembrolizumab for metastatic/recurrent head & neck squamous cell carcinoma
Terrence L. Fisher • 12 Apr 2022
2:45
Ulixertinib in tumors with BRAF fusions, non-V600E or non-V600K BRAF mutations
Vivek Subbiah • 11 Apr 2022
View All Videos

Topics

Trial Updates
Immuno-Oncology
Clinical Practice
Surgery
Molecular Profiling
1:40
MATISSE: nivolumab in cutaneous squamous cell carcinoma
Charlotte Zuur • 4 Jun 2023
1:55
Impact of emotional distress on pathologic response in high-risk stage III melanoma
Irene Reijers • 4 Jun 2023
1:30
Omission of adjuvant therapy and TLND in melanoma: insights from OpACIN-neo, PRADO, and NADINA
Irene Reijers • 4 Jun 2023
2:33
OpACIN-neo & PRADO 3-year results in stage III melanoma: personalized neoadjuvant IO benefits
Irene Reijers • 4 Jun 2023
View All Videos
1:40
MATISSE: nivolumab in cutaneous squamous cell carcinoma
Charlotte Zuur • 4 Jun 2023
1:22
The personalization of neoadjuvant immunotherapy in stage III melanoma
Minke Lucas • 4 Jun 2023
0:40
Gamma signature guidance in optimizing neoadjuvant immunotherapy for resectable melanoma
Minke Lucas • 4 Jun 2023
0:52
Novel advances in PD-1 refractory melanoma
Adnan Khattak • 4 Jun 2023
View All Videos
1:27
Validating MIA & MSKCC predictive tool for melanoma sentinel node status
Roger Olofsson Bagge • 4 Jun 2023
1:22
The personalization of neoadjuvant immunotherapy in stage III melanoma
Minke Lucas • 4 Jun 2023
1:55
Impact of emotional distress on pathologic response in high-risk stage III melanoma
Irene Reijers • 4 Jun 2023
1:30
Omission of adjuvant therapy and TLND in melanoma: insights from OpACIN-neo, PRADO, and NADINA
Irene Reijers • 4 Jun 2023
View All Videos
1:40
MATISSE: nivolumab in cutaneous squamous cell carcinoma
Charlotte Zuur • 4 Jun 2023
1:27
Validating MIA & MSKCC predictive tool for melanoma sentinel node status
Roger Olofsson Bagge • 4 Jun 2023
3:22
Incidence, landscape and survival outcome of de novo malignancy after double lung transplantation
Young Kwang Chae • 3 Jun 2023
1:30
Omission of adjuvant therapy and TLND in melanoma: insights from OpACIN-neo, PRADO, and NADINA
Irene Reijers • 4 Jun 2023
View All Videos
0:42
ctDNA in clinical practice for melanoma
Jason Luke • 16 Apr 2023
1:16
Potential of liquid biopsy as a monitoring tool
Adam Widman • 19 Oct 2022
1:15
The potential applications of ctDNA in melanoma
Matteo Carlino • 11 Oct 2022
3:23
CD8 T-cell receptor signatures of response to checkpoint immunotherapy
Benjamin Fairfax • 10 Sep 2022
View All Videos

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals